Analysis of New Materials and Artificial Turf Products: Influence and Impact on Athlete Performance and Perception
Launched by UNIVERSITY OF CASTILLA-LA MANCHA · Apr 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the impact of new materials used in artificial turf on athletes' performance and their feelings about playing on these surfaces. With recent European regulations aimed at reducing harmful microplastics in sports fields, the trial aims to find safer alternatives that still provide a good playing experience. Researchers will first test different types of turf materials in the lab and then conduct real-life tests with athletes to see how these surfaces affect their performance and perceptions during games.
To participate in this study, players must be between 20 and 30 years old, have played football at a base or amateur level for at least six years, and be free from significant injuries or chronic health issues. Participants will undergo performance tests and answer questions about their experiences on the different turf surfaces. This is a great opportunity for eligible players to contribute to important research that could shape the future of sports facilities and ensure safer playing conditions for everyone.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Gender: Male or female football players. Experience: Players who have played football for at least one full season prior to participating in the study.
- • Playing Level: Players who have played at the base or amateur level for at least 6 years.
- • Health Status: Players who do not have active or chronic injuries that could affect their ability to perform performance tests.
- • Willingness to Participate: Players who are willing to undergo performance tests and complete perception questionnaires.
- • Recent Injury History: Players who have not experienced significant injuries in the three months prior to the start of the study.
- • Medical Conditions: Players who do not have pre-existing medical conditions that could affect their ability to perform performance tests or endanger their health during the tests.
- • Medication: Players who are not taking medications that could affect their ability to perform performance tests.
- • Consent: Players who have signed an informed consent form to participate in the study and are willing to consistently follow the study protocols.
- • Age: Players between 20 and 30 years old (to obtain a more homogeneous sample). -
- • Exclusion Criteria: Recent Injury: Players who have experienced a significant injury in the last three months that required medical attention or could affect their ability to perform performance tests.
- • Chronic Illness: Players who have a chronic illness that could affect their ability to perform performance tests.
- • Medication: Players who are taking medications that could affect their ability to perform performance tests or could affect their understanding of the questionnaires and perception tools.
- • Medical History: Players who have a history of cardiovascular, pulmonary, or neurological disease.
- • Recent Surgery: Players who have had major surgery in the last six months that could affect their ability to perform performance tests.
- • Protocol Compliance: Players who are not willing or able to consistently follow the study protocols.
- • Disability: Players who have a physical or cognitive disability that could affect their ability to perform performance tests.
- • Consent: Players who have not signed an informed consent form to participate in the study.
- • Age: Players who do not meet the minimum and maximum age requirements to be included in the study.
- • -
About University Of Castilla La Mancha
The University of Castilla-La Mancha is a prominent academic institution dedicated to advancing research and innovation in various fields, including health sciences. With a commitment to fostering interdisciplinary collaboration, the university engages in groundbreaking clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Its research initiatives are supported by a robust network of experts and cutting-edge facilities, positioning the university as a leading sponsor in clinical research within the region. Through its rigorous ethical standards and dedication to scientific excellence, the University of Castilla-La Mancha strives to contribute significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported